viscum album/rak

Povezava se shrani v odložišče

Izberite vrsto razvrščanja

13 rezultatov

Trial of Mistletoe Extract in Patients With Advanced Solid Tumors

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

This study is a Phase I study that consists of two phases: a dose escalation phase and an expansion phase. The dose escalation phase will be used to evaluate the safety and toxicity of Helixor® M (mistletoe extract). An accelerated titration design (ATD) will be utilized to determine the MTD. The

Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Extracts from European mistletoe (Viscum album L.) have been used as complementary cancer therapy since the 1920s. To date over 160 clinical studies on mistletoe in cancer therapy have been conducted with varying quality; the therapy is still controversial. Best evidence is found for increase of

Therapeutic Instillation of Mistletoe

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

This is a randomized, open-label, active-controlled, prospective, multinational Phase III confirmative study with 2 treatment groups and an adaptive design (Bauer and Köhne, 1994). The study is designed to compare the efficacy of treatment with abnobaVISCUM® 900 with Mitomycin C (MMC). Patients with

RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

see summary

Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

see summary

Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

The study design is to include 90 subjects. All subjects are treated with the common chemotherapy treatment. 50 percent will be treated with Iscador as combination with their common chemotherapy regimen. Common chemotherapy regimen used for NSCLC: Carboplatin and Gemcitabine. All study participants

Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

The study consists of three parts. Part 1 is a prospective non-randomized feasibility study in patients with breast cancer after primary surgery during chemotherapy or endocrine therapy comparing blood count, lymphocytes, quality of life and local and general side effects between the groups Part 2

Iscar for Supplemental Care in Stage IV Lung Cancer

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

See Brief Summary

Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVES: - Determine whether supplemental treatment with mistletoe increases immune function (as determined by total lymphocyte count, eosinophil count, and lymphocyte subset analysis) in patients with stage IIIB or IV non-small cell lung cancer receiving palliative chemotherapy. - Determine the

Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVES: - Determine the maximum tolerated dose of gemcitabine and mistletoe in patients with advanced solid tumors. - Determine the toxic effects of this regimen in these patients. - Determine the pharmacokinetic effects of gemcitabine with and without mistletoe in these patients. - Determine

Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVES: - Determine the maximum tolerated dose and dose-limiting toxicity of mistletoe lectin (recombinant viscumin) in patients with advanced solid tumors who have failed standard therapy. - Determine the optimal biologically active dose of mistletoe lectin based on analysis of specific

Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVES: - Determine the maximum tolerated dose and dose-limiting toxicity of mistletoe lectin (recombinant viscumin) in patients with advanced solid tumors who have failed standard therapy. - Determine the pharmacokinetics of this regimen in these patients. - Determine whether induction of

Pridružite se naši
facebook strani

Herbal & Natural Medicine

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

Deluje v 55 jezikih
Zeliščna zdravila, podprta z znanostjo
Prepoznavanje zelišč po sliki
Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
Preberite znanstvene publikacije, povezane z vašim iskanjem
Iščite zdravilna zelišča po njihovih učinkih
Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah